wherein A and B are each independently a specialized pro-resolving mediator (“SPM”) molecule selected from an E series resolvin, a D series resolvin, and their aspirin-triggered counterparts, and M, R1, R2, X1and X2 are as defined herein."/>
公开/公告号US10420843B2
专利类型
公开/公告日2019-09-24
原文格式PDF
申请/专利权人 THETIS PHARMACEUTICALS LLC;
申请/专利号US201715824606
发明设计人 FRANK C. SCIAVOLINO;GARY MATHIAS;MICHAEL C. VAN ZANDT;GUNNAR ERIK JAGDMANN JR.;JESSICA J. DWORAK;
申请日2017-11-28
分类号A61K31/202;A61K31/232;A61K38/03;A61K45/06;A61K47/62;A61K47/54;A61P1/04;A61P1/06;A61P1/12;A61P1;A61P29;C07C229/26;C07C237/12;C07C237/22;C07C59/42;
国家 US
入库时间 2022-08-21 12:16:47